Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function

被引:49
作者
Greenstone, HL
Santoro, F
Lusso, P
Berger, EA
机构
[1] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[2] San Raffaele Sci Inst, Dept Biol & Technol Res, Unit Human Virol, I-20132 Milan, Italy
关键词
D O I
10.1074/jbc.M206488200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We employed a quantitative cell fusion assay to identify structural domains of CD46 required for its function as a receptor for human herpesvirus 6 (HHV-6). We examined the activities of recombinant variants of CD46, including different isoforms as well as engineered truncations and molecular chimeras with decay-accelerating factor, a related protein in the family of regulators of complement activation (RCA). We observed strong receptor activity for all four CD46 isoforms, which differ in the membrane-proximal extracellular and cytoplasmic domains, indicating that the critical determinants for HHV-6 receptor activity reside outside the C-terminal portion of CD46. Analysis of the short consensus repeat (SCR) regions that comprise most of the extracellular portion of CD46 indicated a strong dependence on SCRs 2 and 3 and no requirement for SCRs 1 or 4. Fusion-inhibition studies with SCR-specific monoclonal antibodies supported the essential role of SCRs 2 and 3 in HHV-6 receptor activity. These findings contrast markedly with fusion mediated by measles virus glycoproteins for which we observed a strict dependence on SCRs 1 and 2, consistent with previous reports. These results expand the emerging notion that CD46 and other members of the RCA family are co-opted in distinct manners by different infectious pathogens.
引用
收藏
页码:39112 / 39118
页数:7
相关论文
共 54 条
[1]  
ADAMS EM, 1991, J IMMUNOL, V147, P3005
[2]   Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages [J].
Alkhatib, G ;
Broder, CC ;
Berger, EA .
JOURNAL OF VIROLOGY, 1996, 70 (08) :5487-5494
[3]   A HUMAN CELL-SURFACE ANTIGEN DEFINED BY A MONOCLONAL-ANTIBODY AND CONTROLLED BY A GENE ON HUMAN CHROMOSOME-1 [J].
ANDREWS, PW ;
KNOWLES, BB ;
PARKAR, M ;
PYM, B ;
STANLEY, K ;
GOODFELLOW, PN .
ANNALS OF HUMAN GENETICS, 1985, 49 (JAN) :31-39
[4]   Natural measles causes prolonged suppression of interleukin-12 production [J].
Atabani, SF ;
Byrnes, AA ;
Jaye, A ;
Kidd, IM ;
Magnusen, AF ;
Whittle, H ;
Karp, CL .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (01) :1-9
[5]   Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein [J].
Belyakov, IM ;
Wyatt, LS ;
Ahlers, JD ;
Earl, P ;
Pendleton, CD ;
Kelsall, BL ;
Strober, W ;
Moss, B ;
Berzofsky, JA .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8264-8272
[6]   THE BLOCK TO HIV-1 ENVELOPE GLYCOPROTEIN-MEDIATED MEMBRANE-FUSION IN ANIMAL-CELLS EXPRESSING HUMAN CD4 CAN BE OVERCOME BY A HUMAN CELL COMPONENT(S) [J].
BRODER, CC ;
DIMITROV, DS ;
BLUMENTHAL, R ;
BERGER, EA .
VIROLOGY, 1993, 193 (01) :483-491
[7]   Mapping of the primary binding site of measles virus to its receptor CD46 [J].
Buchholz, CJ ;
Koller, D ;
Devaux, P ;
Mumenthaler, C ;
SchneiderSchaulies, J ;
Braun, W ;
Gerlier, D ;
Cattaneo, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22072-22079
[8]   Human herpesvirus 6: An emerging pathogen [J].
Campadelli-Fiume, G ;
Mirandola, P ;
Menotti, L .
EMERGING INFECTIOUS DISEASES, 1999, 5 (03) :353-366
[9]   Compact, synthetic, vaccinia virus early/late promoter for protein expression [J].
Chakrabarti, S ;
Sisler, JR ;
Moss, B .
BIOTECHNIQUES, 1997, 23 (06) :1094-1097
[10]  
CHO SW, 1991, CLIN EXP IMMUNOL, V83, P257